Optical Imaging
Noninvasive virtual biopsy using micro-registered optical coherence tomography (OCT) in human subjects
Science Advances · 2024
Publications
Explore selected publications that represent the lab's work in optical imaging, skin cancer, neurofibromatosis, autoimmune and inflammatory disease, molecular biology, and artificial intelligence.
Highlights
Featured Publications
Skin Cancer & Genetics
Development of a MEK inhibitor, NFX-179, as a chemoprevention agent for squamous cell carcinoma
Science Translational Medicine · 2023
Neurofibromatosis
Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: development, validation and severity strata of the cNF-PUSH-D
British Journal of Dermatology · 2026
Optical Imaging
Optical Imaging
Rapid Cellular-Resolution Skin Imaging with Optical Coherence Tomography Using All-Glass Multifocal Metasurfaces
Zhao J, et al.
ACS Nano · 2023
Optical Imaging
Flexible method for generating needle-shaped beams and its application in optical coherence tomography
Zhao J, et al.
Optica · 2022
Optical Imaging
Angular compounding for speckle reduction in optical coherence tomography using geometric image registration algorithm and digital focusing
Zhao J, et al.
Scientific Reports · 2020
Skin Cancer and Genetics
Skin Cancer & Genetics
Age-dependent cytokine surge in blood precedes cancer diagnosis
Chen G, et al.
Proceedings of the National Academy of Sciences · 2025
Skin Cancer & Genetics
Clinical and Pathologic Phenotyping of Mesotheliomas Developing in Carriers of Germline BAP1 Mutations
Carbone M, et al.
Journal of Thoracic Oncology · 2025
Skin Cancer & Genetics
Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis
Starrett GJ, et al.
Clinical Cancer Research · 2024
Skin Cancer & Genetics
Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling
Novelli F, et al.
Proceedings of the National Academy of Sciences · 2024
Skin Cancer & Genetics
Advances in cutaneous squamous cell carcinoma
Winge MCG, et al.
Nature Reviews Cancer · 2023
Skin Cancer & Genetics
Single-cell analysis of human basal cell carcinoma reveals novel regulators of tumor growth and the tumor microenvironment
Guerrero-Juarez CF, et al.
Science Advances · 2022
Neurofibromatosis
Neurofibromatosis
Measurement of the severity related to cutaneous neurofibromas in neurofibromatosis type 1: Development and validation of the Nef-ASI
Fertitta L, et al.
Journal of the American Academy of Dermatology · 2026
Neurofibromatosis
Phenotypic characterization of neurofibromatosis type 1 in a large Chinese cohort: A cross-sectional study
Wang Z, et al.
JAAD International · 2026
Neurofibromatosis
Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1
Lin MJ, et al.
JAMA Dermatology · 2024
Neurofibromatosis
A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials
Fertitta L, et al.
British Journal of Dermatology · 2024
Neurofibromatosis
Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1
Sarin KY, et al.
Science Advances · 2024
Neurofibromatosis
Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials
Cannon A, et al.
Clinical Trials · 2024
Autoimmune, Inflammatory, and Systemic Disease
Autoimmune & Systemic
The P2X7-NLRP3 inflammasome inhibitor AZD9056 has no significant effect on hidradenitis suppurativa clinical disease activity but restores cytokine production in peripheral blood mononuclear cells: Results of a phase 2 trial
Kilgour JM, et al.
Journal of the American Academy of Dermatology · 2026
Autoimmune & Systemic
TLR7/8 Activation in Immune Cells and Muscle by RNA-Containing Immune Complexes: Role in Inflammation and the Pathogenesis of Myositis
Wu Y, et al.
Arthritis & Rheumatology · 2025
Autoimmune & Systemic
Impaired innate and adaptive immune responses to BNT162b2 SARS-CoV-2 vaccination in systemic lupus erythematosus
Sarin KY, et al.
JCI Insight · 2024
Autoimmune & Systemic
The Type I Interferon Signature Reflects Multiple Phenotypic and Activity Measures in Dermatomyositis
Tabata MM, et al.
Arthritis & Rheumatology · 2023
Autoimmune & Systemic
Transcriptomic Repositioning Analysis Identifies mTOR Inhibitor as Potential Therapy for Epidermolysis Bullosa Simplex
Lee GH, et al.
Journal of Investigative Dermatology · 2022
Autoimmune & Systemic
Characterization of comorbidity heterogeneity among 13,667 patients with hidradenitis suppurativa
Hua VJ, et al.
JCI Insight · 2021